Literature DB >> 15065083

Met160Val polymorphism in the TRMPSS2 gene and risk of prostate cancer in a population-based case-control study.

Joanna M Lubieniecka1, Mahesh Keitheri Cheteri, Janet L Stanford, Elaine A Ostrander.   

Abstract

BACKGROUND: Serine proteases play an important role in prostate cancer (PCa) invasion through the degradation of extracellular matrix proteins and interaction with growth modulating factors. The transmembrane serine protease 2 (TMPRSS2) gene encodes a type II transmembrane protein which, due to its cell surface localization, could be a potentially useful predictive marker for PCa.
METHODS: We screened a population of 24 unrelated individuals for sequence variants in the TMPRSS2 gene, and found a Met160Val change in 33%. We then tested 559 cases and 523 controls from a population-based case-control study of middle-aged men from Washington State.
RESULTS: Men with the GG genotype and a first-degree family history of PCa had a significantly higher risk for PCa relative to men without a family history (OR = 2.05; 95% CI = 1.3-3.2). However, the interaction between genotype and family history of PCa was not significant (P = 0.52).
CONCLUSIONS: Larger, more detailed studies are needed to fully investigate the role of serine proteases in PCa. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15065083     DOI: 10.1002/pros.20005

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  7 in total

1.  Racial differences in prediction of time to prostate cancer diagnosis in a prospective screening cohort of high-risk men: effect of TMPRSS2 Met160Val.

Authors:  Veda N Giri; Karen Ruth; Lucinda Hughes; Robert G Uzzo; David Y T Chen; Stephen A Boorjian; Rosalia Viterbo; Timothy R Rebbeck
Journal:  BJU Int       Date:  2010-08-24       Impact factor: 5.588

2.  Phenotypic analysis of mice lacking the Tmprss2-encoded protease.

Authors:  Tom S Kim; Cynthia Heinlein; Robert C Hackman; Peter S Nelson
Journal:  Mol Cell Biol       Date:  2006-02       Impact factor: 4.272

Review 3.  miRNAs as drivers of TMPRSS2-ERG negative prostate tumors in African American men.

Authors:  Clayton Yates; Mark D Long; Moray J Campbell; Lara Sucheston-Campbell
Journal:  Front Biosci (Landmark Ed)       Date:  2017-01-01

4.  Initial study on TMPRSS2 p.Val160Met genetic variant in COVID-19 patients.

Authors:  Laksmi Wulandari; Berliana Hamidah; Cennikon Pakpahan; Nevy Shinta Damayanti; Neneng Dewi Kurniati; Christophorus Oetama Adiatmaja; Monica Rizky Wigianita; Dominicus Husada; Damayanti Tinduh; Cita Rosita Sigit Prakoeswa; Anang Endaryanto; Ni Nyoman Tri Puspaningsih; Yasuko Mori; Maria Inge Lusida; Kazufumi Shimizu; Delvac Oceandy
Journal:  Hum Genomics       Date:  2021-05-17       Impact factor: 4.639

Review 5.  Molecular mechanisms involved in anosmia induced by SARS-CoV-2, with a focus on the transmembrane serine protease TMPRSS2.

Authors:  Ali Karimian; Mohaddeseh Behjati; Mohammad Karimian
Journal:  Arch Virol       Date:  2022-08-08       Impact factor: 2.685

6.  Association of TMPRSS2-ERG gene fusion with clinical characteristics and outcomes: results from a population-based study of prostate cancer.

Authors:  Liesel M FitzGerald; Ilir Agalliu; Karynn Johnson; Melinda A Miller; Erika M Kwon; Antonio Hurtado-Coll; Ladan Fazli; Ashish B Rajput; Martin E Gleave; Michael E Cox; Elaine A Ostrander; Janet L Stanford; David G Huntsman
Journal:  BMC Cancer       Date:  2008-08-11       Impact factor: 4.430

7.  Status of TMPRSS2-ERG fusion in prostate cancer patients from India: correlation with clinico-pathological details and TMPRSS2 Met160Val polymorphism.

Authors:  Aparna Bhanushali; Pranesh Rao; Vaishnavi Raman; Prajakta Kokate; Asawari Ambekar; Swarna Mandva; Simi Bhatia; B R Das
Journal:  Prostate Int       Date:  2018-03-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.